jRCT2080225159已完成2 期
Effects of adrenomedullin in steroid-resistant patients with ulcerative colitis: randomized, double-blind, placebo-controlled phase 2a clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multicenter, Randomized, Double-blind, Placebo-controlled Study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 18age old over 至 75age old under（—）
- 性别
- All
入选标准
- •patients with steroid-resistant ulcerative colitis
排除标准
- •Patient using biologics
- •Patient with fulminant ulcerative colitis (UC)
- •Patient need early operation for UC
- •Patient with precancerous lesion(s) in the colon
- •Patient with active infection
- •Patient with severe complication(s)
- •Patient with malignancy or past history of malignancy
- •Pregnant woman
结局指标
主要结局
-
efficacy change of Mayo scores at week 2
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase II trial in treatment of gastrointestinal fistulas with endoscopic injection of an alpha-cyanoacrylate monomerGastrointetinal fistulasJPRN-UMIN000018486Second Department of Surgery, Wakayama Medical University, School of Medicine20
撤回
不适用
Clinical trial for amelioration of bowel uptake in PET/CTNeoplasmsKCT0001162Seoul National University Bundang Hospital300
进行中（未招募）
1 期
Study to evaluate the efficacy of FOLFIRI + aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without ACE polymorphismsMetastatic colorectal cancerMedDRA version: 19.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2016-001508-45-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)100
进行中（未招募）
1 期
Randomised clinical trial to test if silibinin administration can prevent the respiratory failure secondary to the COVID19 lung infection in oncologic patients.COVID19 respiratory failureEUCTR2020-001794-77-ESINSTITUT CATALÀ D'ONCOLOGIA GIRONA - HOSPITAL JOSEP TRUETA92
尚未招募
不适用
Phase Ib/II Clinical Trial to Evaluate the efficacy and safety of Neo-adjuvant chemotherapy with Autologous Cytokine-Induced Killer Cells Therapy in patients with estrogen receptor negative/HER-2 negative breast cancerKCT0008408ational Cancer Center51